ArticleClinical, cosmetic and investigational dermatology2026
Pruritus in Europe's Aging Populations: Regional and National Patterns, 1990-2023, and Forecasts to 2050: A Systematic Analysis for the Global Burden of Disease Study 2023.
Article in Clinical, cosmetic and investigational dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Pruritus is a common and distressing symptom among older adults, yet long-term patterns and regional differences across Europe remain insufficiently characterized. As European populations age rapidly, understanding how the burden of pruritus has evolved and may change is essential for clinical and public health planning. Methods: Using Global Burden of Disease (GBD) 2023 estimates, we quantified incidence, prevalence, and disability-adjusted life years (DALYs) of pruritus among adults aged over 60 years in Central, Eastern, and Western Europe from 1990 to 2023. Age-standardized rates and case numbers were extracted for 5-year age groups by sex and country. Temporal trends were evaluated using estimated annual percentage change (EAPC) and Joinpoint regression. Future burden to 2050 was projected with Bayesian age-period-cohort models using Integrated Nested Laplace Approximation. All estimates included 95% uncertainty intervals. Results: From 1990 to 2023, age-standardized incidence, prevalence, and DALY rates increased significantly across all three European regions. In 2023, Central Europe exhibited the highest rates, whereas Western Europe had the largest absolute numbers of affected individuals. Females consistently showed higher rates and earlier peak ages than males. Age-specific curves demonstrated an inverted-U shape, and country rankings were generally aligned with long-term EAPC patterns. Projections suggest continued growth in incident and prevalent cases and DALYs through 2050, especially in Western Europe, with persistent sex- and age-related disparities. Conclusion: The burden of pruritus among older adults in Europe has risen steadily over the past three decades and is projected to increase further. Integrating routine itch assessment, optimized skin care, medication review, and strengthened referral pathways into primary, geriatric, and long-term care services is urgent to mitigate preventable disability in aging populations.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.